Biochemistry 2: Complete Citric Acid Cycle Study Guide

Overview and Principles of Cellular Metabolism

• Energy Recovery Beyond Glycolysis:

  • Although glucose is an essential energy source for nearly all cells, glycolysis alone recovers only a fraction of the total chemical potential energy present in carbohydrates.
  • In anaerobic glycolysis, glucose is converted to relatively reduced end products such as lactate or ethanol, which are excreted from the cell, leaving most energy unextracted.
  • Complete oxidation of metabolic fuels yields significantly higher quantities of ATP.

• Role of Electron Acceptors in Aerobic Respiration:

  • Oxidation of organic compounds requires external electron acceptors such as $\text{NO}_3^-$), $\text{SO}_4^{2-}$), $\text{Fe}^{3+}$), or $\text{O}_2$.
  • Aerobic organisms utilize molecular oxygen ($\text{O}_2$) as the ultimate electron acceptor for oxidative metabolism.
  • As reduced carbon atoms are oxidized to $\text{CO}_2$, electrons are transferred to electron carriers ($\text{NAD}^+$ and $\text{FAD}$) that are subsequently reoxidized via the mitochondrial electron transport chain.

• Evolutionary Origin and Function:

  • The citric acid cycle evolved approximately $3 \times 10^6$ years ago (3 million years ago).
  • It acts as an essential addendum to glycolysis rather than a simple continuation.
  • Pyruvate derived from glucose is split into $\text{CO}_2$ and a two-carbon fragment that enters the cycle for oxidation as acetyl-CoA.

• Central Hub of Metabolism:
  • The citric acid cycle serves as the metabolic hub of the cell, recovering energy from carbohydrates, fatty acids, and amino acids, all of which are catabolized to acetyl-CoA for oxidation.
  • Under specific physiological conditions, its principal function is energy recovery from fatty acid breakdown.
  • It concurrently supplies intermediate reactants for numerous biosynthetic (anabolic) pathways.

• Fundamental Definitions and Terminology:

  • Definition: An eight-reaction pathway that oxidizes the acetyl group of acetyl-CoA to two molecules of $\text{CO}_2$ while conserving liberated free energy as reduced compounds ($\text{NADH}$ and $\text{FADH}_2$).
  • Nomenclature:
    • Citric Acid Cycle: Named after citrate, the primary product formed in the initial step.
    • Krebs Cycle: Named after its discoverer, Hans Krebs.
    • Tricarboxylic Acid (TCA) Cycle: Refers to the three carboxyl groups present on citrate.

• Subcellular Localization:

  • In eukaryotes, all citric acid cycle enzymes reside within the mitochondrial matrix, with the sole exception of succinate dehydrogenase, which is integrated directly into the inner mitochondrial membrane.
  • All required substrates, cofactors, and nucleotides ($\text{NAD}^+$, $\text{GDP}$, $\text{P}_i$) must either be present within or imported into the mitochondrial matrix.

• Multistep Catalytic Nature:

  • Because oxaloacetate consumed in the first reaction is regenerated in the final reaction, the cycle functions as a multistep catalyst capable of oxidizing an unlimited number of acetyl groups.
  • Net reaction per round:

$3\,\text{NAD}^+ + \text{FAD} + \text{GDP} + \text{P}_i + \text{acetyl-CoA} \rightarrow 3\,\text{NADH} + \text{FADH}_2 + \text{GTP} + \text{CoA} + 2\,\text{CO}_2$

• Carbon Origin and Electron Transfer Yields:
  • The two carbon atoms released as $\text{CO}_2$ during a single turn of the cycle are not the same two carbon atoms entering as the acetyl group in that specific round; those carbons are eliminated in subsequent turns.
  • Complete oxidation of one acetyl group to $2\,\text{CO}_2$ requires the transfer of four pairs of electrons:
    • Three pairs are transferred during the reduction of $3\,\text{NAD}^+$ to $3\,\text{NADH}$.
    • One pair is transferred during the reduction of $\text{FAD}$ to $\text{FADH}_2$.
  • Reoxidation of these four electron pairs by $\text{O}_2$ via electron transport and oxidative phosphorylation drives the generation of approximately $10\,\text{ATP}$ per acetyl group.

Synthesis of Acetyl-CoA and the Pyruvate Dehydrogenase Complex

• Mitochondrial Entry of Pyruvate:

  • Under aerobic conditions, glycolytic $\text{NADH}$ is reoxidized in the mitochondria, yielding pyruvate as the final glycolytic product in the cytosol.
  • Pyruvate enters the mitochondrial matrix via a specific transport protein using a $\text{pyruvate--H}^+$ symport mechanism.

• High-Energy Thioester Linkage:

  • Acetyl groups enter the cycle joined to Coenzyme A (CoA) via a high-energy thioester bond ($\text{acetyl-CoA}$).
  • Hydrolysis of this thioester releases significant free energy, driving downstream condensation reactions.

• Multienzyme Complexes and Structural Organization:

  • Pyruvate is converted to acetyl-CoA by the pyruvate dehydrogenase complex, a noncovalently associated multienzyme assembly.
  • Evolutionary Advantages of Multienzyme Complexes:
    1. Enhanced Reaction Rates: Distance between active sites is minimized, reducing substrate diffusion time between sequential steps.
    2. Channeling of Intermediates: Direct passage of substrates between active sites minimizes side reactions and prevents intermediate loss.
    3. Coordinate Control: Enables synchronized regulation of all catalytic units within the complex.

• Subunit Composition of Pyruvate Dehydrogenase:

  • In mammals, yeast, and several bacteria, it represents the largest known multienzyme complex, with a total mass of $\sim 10,000\,\text{kDa}$.
  • Structural Core: Made of dihydrolipoyl transacetylase (E2), containing $60\,\text{subunits}$ arranged in dodecahedral symmetry ($20\,\text{vertices}$, $12\,\text{pentagonal faces}$).
  • Outer Shell: Composed of $\sim 45\,\text{E1}$ $\alpha_2\beta_2$ heterotetramers and $\sim 9\,\text{E3}$ homodimers surrounding the E2 core.
  • E1 and E3 bind competitively to mutually exclusive sites on the interior E2 core in a random distribution.
  • An E3-binding protein facilitates attachment of E3 to E2, accompanied by regulatory kinase and phosphatase enzymes.

• Enzymatic Components and Required Coenzymes:

  • Three Catalytic Subunits:
    1. Pyruvate dehydrogenase (E1)
    2. Dihydrolipoyl transacetylase (E2)
    3. Dihydrolipoyl dehydrogenase (E3)
  • Five Coenzymes:
    1. Thiamine pyrophosphate (TPP)
    2. Lipoamide
    3. Coenzyme A (CoA)
    4. Flavin adenine dinucleotide (FAD)
    5. Nicotinamide adenine dinucleotide ($\text{NAD}^+$)
  • Overall Reaction Stoichiometry:

$\text{Pyruvate} + \text{CoA} + \text{NAD}^+ \rightarrow \text{acetyl-CoA} + \text{CO}_2 + \text{NADH}$

• Step-by-Step Reaction Mechanism of the PDH Complex:
  1. Formation of Hydroxyethyl-TPP (catalyzed by E1):
     • E1 requires TPP to decarboxylate pyruvate, forming a hydroxyethyl-TPP intermediate and releasing $\text{CO}_2$

2.  *Formation of Dihydrolipoamide (catalyzed by E2)*:
    *   The hydroxyethyl group is transferred from TPP to lipoamide on E2.
    *   Lipoamide consists of lipoic acid linked via an amide bond to the $\varepsilon$-amino group of a Lysine residue.
    *   The cyclic disulfide center of lipoamide is reduced by the hydroxyethyl carbanion, forming acetyl-dihydrolipoamide and regenerating active TPP on E1.

3.  *Formation of Acetyl-CoA (catalyzed by E2)*:
    *   E2 catalyzes transesterification, transferring the acetyl group from dihydrolipoamide to CoA.
    *   Produces acetyl-CoA and leaves E2 in the reduced dihydrolipoamide state.

4.  *Reoxidation of Dihydrolipoamide (catalyzed by E3)*:
    *   E3 reoxidizes dihydrolipoamide to lipoamide on E2 via disulfide interchange.
    *   E3 contains a reactive Cysteine-Cysteine ($\text{Cys--Cys}$) disulfide group and tightly bound $\text{FAD}$, both of which accept electrons to become reduced E3.

5.  *Regeneration of E3 and Production of NADH*:
    *   Reduced E3 transfers electrons from its reduced sulfhydryl groups and $\text{FADH}_2$ to $\text{NAD}^+$.
    *   Re-establishes oxidized E3 and yields $\text{NADH} + \text{H}^+$, which exits to the electron transport chain.

• Substrate Channeling via Swinging Arm Mechanism:

  • The lipoamide group of E2 acts as a flexible $\sim 14\,\text{\AA}$ swinging arm (lipoic acid + Lysine side chain).
  • This arm is linked to the core by a flexible, Proline- and Alanine-rich segment extending $> 140\,\text{\AA}$.
  • The tether swings between E1 (to acquire hydroxyethyl), the E2 core (to form acetyl-CoA), and E3 (for reoxidation).
  • This extended reach permits a single E1 protein to acetylate multiple E2 subunits, and a single E3 protein to reoxidize multiple dihydrolipoamides.

• Toxicity Warning:

  • Certain arsenic-containing compounds react specifically with the reduced dihydrolipoamide sulfhydryl groups of E2, inactivating the entire pyruvate dehydrogenase complex.

Step-by-Step Reactions of the Citric Acid Cycle

Phase I: Condensation and Decarboxylation Reactions

• Step 1: Condensation of Acetyl-CoA and Oxaloacetate (Citrate Synthase):
  • Reaction: Condensation of acetyl moiety from acetyl-CoA with oxaloacetate to form citrate ($6\,\text{C}$).
  • Enzyme Class: Synthase (catalyzes covalent bond formation without requiring direct ATP input).
  • Thermodynamics: Strongly exergonic ($\Delta G^{\circ\prime} = -32.2\,\text{kJ}\cdot\text{mol}^{-1}$) due to hydrolysis of the thioester bond.
  • Mechanism: Exhibits ordered sequential kinetic behavior.
    1. Oxaloacetate binds first to the open homodimeric enzyme.
    2. Binding induces a $180^\circ$ domain rotation (a conformational shift moving relative interatomic distances up to $15\,\text{\AA}$ and domain rotations of $18^\circ$).
    3. This closes the cleft, creates the acetyl-CoA binding site, and seals oxaloacetate from solvent contact, preventing premature hydrolysis of acetyl-CoA (similar to domain closure in hexokinase).

• Step 2: Isomerization of Citrate to Isocitrate (Aconitase):
  • Reaction: Reversible isomerization converting citrate to isocitrate ($6\,\text{C}$) via the intermediate cis-aconitate.
  • Two-Stage Process:
    1. Dehydration: Removal of $\text{OH}^-$ and $\text{H}^+$ from citrate forming double-bonded cis-aconitate.
    2. Rehydration: Stereospecific addition of $\text{H}_2\text{O}$ across the double bond to yield isocitrate.
  • Metabolic Rationale: Citrate is a tertiary alcohol and cannot be oxidized; isomerization converts it to isocitrate, an oxidizable secondary alcohol.
  • Prochirality and Iron-Sulfur Cluster:
    • Citrate is prochiral. Aconitase removes water exclusively from citrate's lower carboxymethyl arm.
    • Contains a $[4\text{Fe}-4\text{S}]$ iron-sulfur cluster that coordinates the hydroxyl group of citrate to facilitate elimination.

*   *Moonlighting Function (Iron Regulatory Protein-1)*:
    *   When cellular iron levels drop, aconitase loses its $[4\text{Fe}-4\text{S}]$ cluster and undergoes conformational change into Iron Regulatory Protein 1 (IRP1).
    *   IRP1 binds specific sequences on transferrin receptor mRNA (inhibiting its degradation to increase iron uptake) and ferritin mRNA (blocking translation to decrease iron storage).
    *   Excess systemic iron causes toxic accumulation in the liver, heart, and pancreas, leading to hemochromatosis.
*   *Inhibition by Fluoroacetate*:
    *   Fluoroacetate is a potent rodenticide that crosses membranes easily.
    *   Functions as a "Trojan horse inhibitor": converted into fluoroacetyl-CoA by acetyl-CoA synthetase, condensed with oxaloacetate by citrate synthase to yield **fluorocitrate**, which strongly inhibits aconitase.

• Step 3: First Oxidative Decarboxylation (Isocitrate Dehydrogenase):
  • Reaction: Oxidative decarboxylation of isocitrate to $\alpha$-ketoglutarate ($5\,\text{C}$).
  • Mechanism:
    1. Isocitrate is oxidized by hydride transfer to $\text{NAD}^+$ (or $\text{NADP}^+$), generating oxalosuccinate.
    2. $\text{Mn}^{2+}$ or $\text{Mg}^{2+}$ cofactors polarize the newly formed carbonyl group, facilitating decarboxylation of the carboxyl group $\beta$ to the ketone.
    3. Rearrangement of the enol intermediate yields $\alpha$-ketoglutarate.
  • Significance: Releases the first molecule of $\text{CO}_2$ and generates the first $\text{NADH}$ connecting the cycle to the electron transport chain. Provides $\alpha$-ketoglutarate, an essential intermediate connecting carbohydrate and protein metabolism.

• Step 4: Second Oxidative Decarboxylation ($\alpha$-Ketoglutarate Dehydrogenase Complex):
  • Reaction: Oxidative decarboxylation of $\alpha$-ketoglutarate to succinyl-CoA ($4\,\text{C}$).
  • Multienzyme Structure: Multienzyme complex structurally analogous to the pyruvate dehydrogenase complex, comprising:
    1. $\alpha$-ketoglutarate dehydrogenase (E1)
    2. Dihydrolipoyl transsuccinylase (E2)
    3. Dihydrolipoyl dehydrogenase (E3) -- identical to E3 in PDH.
  • Cofactors: Thiamine pyrophosphate (TPP, Vitamin $B_1$), $\text{Mg}^{2+}$, lipoamide, CoA, FAD, and $\text{NAD}^+$.
  • Product: Succinyl-CoA, a high-energy thioester compound, accompanied by $\text{CO}_2$ and $\text{NADH}$.
  • Related Enzyme: Branched-chain $\alpha$-keto acid dehydrogenase belongs to this same enzyme family and metabolizes Isoleucine, Leucine, and Valine.

Phase II: Regeneration of Oxaloacetate

• Step 5: Substrate-Level Phosphorylation (Succinyl-CoA Synthetase):
  • Reaction: Cleavage of the high-energy thioester bond of succinyl-CoA coupled to nucleoside triphosphate synthesis, forming succinate ($4\,\text{C}$).
  • Synonym: Succinate Thiokinase.
  • Mechanism:
    1. Succinyl-CoA undergoes nucleophilic attack by inorganic phosphate to form succinyl-phosphate (high-energy acyl-phosphate intermediate) and CoA-SH.
    2. The phosphoryl group is transferred to an active-site Histidine residue on the enzyme, releasing succinate.
    3. The phosphoryl group is subsequently transferred to GDP (in mammals) or ADP (in plants/bacteria) to form GTP or ATP.
  • Thermodynamics: Cleavage of succinyl-CoA ($\Delta G^{\circ\prime} = -32.6\,\text{kJ}\cdot\text{mol}^{-1}$) powers nucleoside triphosphate formation ($\Delta G^{\circ\prime} = +30.5\,\text{kJ}\cdot\text{mol}^{-1}$), yielding an overall $\Delta G^{\circ\prime} = -3.3\,\text{kJ}\cdot\text{mol}^{-1}$.
  • Interconversion: $\text{GTP}$ and $\text{ATP}$ are rapidly interconverted via nucleoside diphosphate kinase with zero free energy change:

$\text{GTP} + \text{ADP} \rightleftharpoons \text{GDP} + \text{ATP} \quad (\Delta G^{\circ\prime} = 0)$

• Step 6: Dehydrogenation of Succinate (Succinate Dehydrogenase):
  • Reaction: Removal of two hydrogen atoms from succinate to form fumarate ($4\,\text{C}$) containing a trans double bond.
  • Localization: The only membrane-bound enzyme of the cycle, located in the inner mitochondrial membrane (Complex II of the electron transport chain).
  • Prosthetic Group: Contains an $\text{FAD}$ group covalently linked to a Histidine residue.
  • Reoxidation: Electrons extracted from alkane oxidation (succinate to fumarate alkene) convert $\text{FAD}$ to $\text{FADH}_2$, which funnels electrons directly into the mitochondrial electron transport chain.

*   *Inhibition by Malonate*:
    *   Malonate is a structural analog of succinate and acts as a classic competitive inhibitor.
    *   Hans Krebs used malonate inhibition of cellular respiration to prove that succinate is a catalytic intermediate in a cycle rather than a linear reaction substrate.

• Step 7: Hydration of Fumarate (Fumarase):
  • Reaction: Stereospecific hydration across the trans double bond of fumarate to yield L-malate ($4\,\text{C}$).
  • Mechanism: Nucleophilic addition of $\text{OH}^-$ creates a carbanion transition state, followed by $\text{H}^+$ addition.
  • Stereospecificity: Produces exclusively the L-isomer of malate.

• Step 8: Regeneration of Oxaloacetate (Malate Dehydrogenase):
  • Reaction: Oxidation of L-malate back to oxaloacetate ($4\,\text{C}$) with concomitant reduction of $\text{NAD}^+$ to $\text{NADH}$.
  • Thermodynamics and Coupling:
    • This reaction is strongly endergonic under standard conditions ($\Delta G^{\circ\prime} = +29.2\,\text{kJ}\cdot\text{mol}^{-1}$ or $+29.7\,\text{kJ}\cdot\text{mol}^{-1}$).
    • At equilibrium, cellular concentrations of oxaloacetate are extremely low.
    • The reaction is pulled continuously forward in vivo because the product oxaloacetate is immediately consumed by the highly exergonic citrate synthase reaction ($\Delta G^{\circ\prime} = -31.5\,\text{kJ}\cdot\text{mol}^{-1}$ to $-32.2\,\text{kJ}\cdot\text{mol}^{-1}$).

Quantitative Energetics and Reaction Summary

• Comprehensive Reaction Summary Table:

• Overall Stoichiometric Equation:

$\text{Acetyl-CoA} + 3\,\text{NAD}^+ + \text{FAD} + \text{GDP} + \text{HPO}_4^{2-} (\text{P}_i) + 2\,\text{H}_2\text{O} \rightarrow 2\,\text{CO}_2 + \text{CoA-SH} + 3\,\text{NADH} + 3\,\text{H}^+ + \text{FADH}_2 + \text{GTP}$

• Carbon Balance Throughout Cycle Steps:
  • The carbon atom flow through intermediate steps follows:

$3 \rightarrow 6 \rightleftharpoons 6 \rightarrow 5 \rightarrow 4 \rightarrow 4 \rightarrow 4 \rightarrow 4 \rightarrow 4$

• Required Vitamin Cofactors:

  1. Vitamin $B_1$ (Thiamine): Thiamine pyrophosphate (TPP) used by PDH and $\alpha$-ketoglutarate dehydrogenase complex.
  2. Vitamin $B_2$ (Riboflavin): Component of $\text{FAD}$ in succinate dehydrogenase and dehydrogenase complexes.
  3. Vitamin $B_3$ (Niacin): Component of $\text{NAD}^+$ utilized in dehydrogenase steps.
  4. Vitamin $B_5$ (Pantothenic Acid): Component of Coenzyme A (CoA).

• Net Pathway Energetics:

  • Overall standard free energy change for one full turn of the citric acid cycle is exergonic:

$\Delta G^{\circ\prime} = -44.3\,\text{kJ}\cdot\text{mol}^{-1}$

Regulatory Mechanisms of Pathway Control

• Active vs. Resting Metabolic States:

• Regulation of Pyruvate Dehydrogenase (PDH Complex):
  • Product Inhibition:
    • High ratios of $[\text{NADH}]/[\text{NAD}^+]$ and $[\text{acetyl-CoA}]/[\text{CoA}]$ cause product inhibition.
    • E2 stays in the acetylated form, holding TPP on E1 in the hydroxyethyl-TPP form, thereby decreasing pyruvate decarboxylation.
  • Covalent Modification by Phosphorylation:
    • Pyruvate Dehydrogenase Kinase: Phosphorylates a specific Serine residue on E1, inactivating the complex and decreasing acetyl-CoA synthesis.
    • Pyruvate Dehydrogenase Phosphatase: Removes the phosphate group from E1, restoring catalytic activity.
  • Metabolite and Hormonal Effectors:
    • Pyruvate and ADP inhibit PDH kinase (keeping PDH active during high substrate/low energy conditions).
    • $\text{Ca}^{2+}$ inhibits PDH kinase and activates PDH phosphatase (stimulating ATP production during muscle contraction).
    • Insulin: Signals fuel abundance in response to high blood glucose, activating PDH phosphatase to promote acetyl-CoA synthesis.

• Three Primary Intrinsic Control Sites in the Cycle:
  1. Citrate Synthase (Site 1): Allosterically inhibited by ATP, NADH, Succinyl-CoA, CoA, and its own product, citrate.
  2. Isocitrate Dehydrogenase (Site 2): Allosterically inhibited by ATP and NADH; allosterically activated by ADP and $\text{NAD}^+$. The enzyme is almost completely inactive in the absence of ADP.
  3. $\alpha$-Ketoglutarate Dehydrogenase Complex (Site 3): Allosterically inhibited by ATP, NADH, and its product, Succinyl-CoA; activated by ADP and $\text{NAD}^+$.

Amphibolic Nature: Anaplerotic and Cataplerotic Pathways

• Amphibolic Definition:

  • The citric acid cycle is amphibolic -- operating in both catabolic (oxidizing acetyl groups to release energy) and anabolic (supplying precursor intermediates for biosynthesis) capacities.
  • Cycle intermediates must be maintained at catalytic concentrations for continuous cellular respiration.

• Cataplerotic Reactions (Intermediates Drained for Biosynthesis):

  • Cataplerotic means "emptying down" (draining intermediates to synthesize other molecules and prevent toxic mitochondrial accumulation).
  • Primary Cataplerotic Pathways:
    1. Gluconeogenesis: Oxaloacetate is removed from the mitochondria (converted to malate or aspartate for cytosolic transport) to synthesize glucose.
    2. Fatty Acid and Sterol Biosynthesis: Cytosolic fatty acid synthesis requires acetyl-CoA. Mitochondrial acetyl-CoA condenses to citrate, crosses into the cytosol, and is cleaved by ATP-citrate lyase:

$\text{ATP} + \text{citrate} + \text{CoA} \rightarrow \text{ADP} + \text{P}_i + \text{oxaloacetate} + \text{acetyl-CoA}$

    3.  *Amino Acid Biosynthesis*: $\alpha$-Ketoglutarate undergoes reductive amination by glutamate dehydrogenase (using $\text{NADH}$ or $\text{NADPH}$) to form Glutamate. Oxaloacetate undergoes transamination with Alanine to yield Aspartate and Pyruvate.
    4.  *Porphyrin, Chlorophyll, and Heme Biosynthesis*: Utilizes Succinyl-CoA as a structural precursor.

• Anaplerotic Reactions (Replenishing Drained Intermediates):
  • Anaplerotic means "filling up" (replenishing cycle intermediates that were siphoned off).
  • Pyruvate Carboxylase (Major Anaplerotic Step):
    • Catalyzes direct carboxylation of pyruvate to oxaloacetate:

$\text{Pyruvate} + \text{CO}_2 + \text{ATP} + \text{H}_2\text{O} \rightarrow \text{oxaloacetate} + \text{ADP} + \text{P}_i$

    *   Activated allosterically by **acetyl-CoA**. When cycle intermediates drop, acetyl-CoA accumulates, activating pyruvate carboxylase to regenerate oxaloacetate.
*   *Exercise Physiology Dynamics*: During intense muscle exercise, pathway flux increases $60\text{-}$ to $100\text{-fold}$. Glycolytic pyruvate is converted to oxaloacetate via pyruvate carboxylase and transaminated with glutamate to yield alanine and $\alpha$-ketoglutarate, supporting high acetyl group clearance.
*   *Other Anaplerotic Inputs*: Oxidation of odd-chain fatty acids and breakdown of Isoleucine, Methionine, and Valine yield Succinyl-CoA; Aspartate, Phenylalanine, and Tyrosine yield Fumarate.

The Glyoxylate Cycle and Medical Implications

• Overview of the Glyoxylate Cycle:
  • Operates in plants, bacteria, and fungi (absent in animals), permitting the net conversion of acetyl-CoA into oxaloacetate for gluconeogenesis.
  • Bypasses the two $\text{CO}_2$-releasing decarboxylation steps of the citric acid cycle.
  • Operates across two cellular compartments: the glyoxysome (a specialized plant peroxisome) and the mitochondrion.

• Step-by-Step Pathway of the Glyoxylate Cycle:

  1. Citrate Formation: Glyoxysomal oxaloacetate condenses with acetyl-CoA via citrate synthase to form citrate.
  2. Isomerization: Citrate is isomerized to isocitrate by aconitase (occurring in the cytosol, as glyoxysomes lack aconitase).
  3. Cleavage by Isocitrate Lyase: Isocitrate lyase cleaves isocitrate into succinate ($4\,\text{C}$) and glyoxylate ($2\,\text{C}$).
  4. Malate Formation by Malate Synthase: Malate synthase condenses glyoxylate with a second molecule of acetyl-CoA to form malate.
  5. Oxidation: Glyoxysomal malate dehydrogenase oxidizes malate to oxaloacetate using $\text{NAD}^+$.

• Fates of Produced Succinate and Net Equation:

  • Succinate produced by isocitrate lyase enters the mitochondrion, joins the citric acid cycle, and forms malate.
  • This malate is either converted to oxaloacetate inside mitochondria to maintain respiration or exported to the cytosol for gluconeogenesis.
  • Net Stoichiometry:

$2\,\text{Acetyl-CoA} + 2\,\text{NAD}^+ + \text{FAD} \rightarrow \text{oxaloacetate} + 2\,\text{CoA} + 2\,\text{NADH} + \text{FADH}_2 + 2\,\text{H}^+$

• Biological Significance in Plants and Human Metabolic Limitations:

  • Allows germinating oilseeds to convert stored triacylglycerol lipids into glucose.
  • Arabidopsis thaliana Study: A mutant lacking isocitrate lyase could still germinate, but failed when subjected to low-light conditions, demonstrating that the primary importance of the glyoxylate cycle during seedling growth is its anaplerotic supply of four-carbon units.
  • Human Metabolic Limitation: Humans lack isocitrate lyase and malate synthase. Consequently, humans cannot achieve net synthesis of carbohydrates (glucose) from fatty acids/acetyl-CoA, as acetyl carbons are lost as $\text{CO}_2$.

• Medical and Pharmacological Implications:

  • Mycobacterium tuberculosis: The causative agent of tuberculosis resides inside human lungs for long periods by subsisting on host lipids. It utilizes the citric acid cycle for amino acid precursors and the glyoxylate cycle for carbohydrate synthesis. Inhibiting bacterial isocitrate lyase represents a targeted antibiotic drug strategy.
  • Candida albicans: Virulence of this opportunistic yeast pathogen in immunosuppressed patients relies on glyoxylate cycle activation upon phagocytosis by macrophages.